RxDoctor Payments Data

Charles Brooks

Gastroenterology · Allentown, PANPI 1750373155

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $790 and has fallen 98.3% since, to $13 in 2023.

$2,338in general payments, 2019–2025

Across 148 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$501
  • Johnson & Johnson$337
  • Pfizer$232
  • Takeda Pharmaceuticals U.S.A., Inc.$213
  • Gilead$175
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$160
  • plus $719 from 15 others

What the payments were for

  • Food & beverage$2,338100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,338 in reported general payments places this provider in the 55th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania →

Other gastroenterology in Allentown

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →